Geno Germano reports a stock award at Eloxx Pharmaceuticals

By AlphaYouPublished Oct 21, 2026Form 4

Stocks in this disclosure

Reported activity

Germano Geno J

Reporting filer

Geno Germano reports a stock award, not an open-market purchase or sale, in Eloxx Pharmaceuticals, Inc.. Form 4 filed Oct 21, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Option (Right to Buy) (derivative)	Germano Geno J	2026-10-19	A	Grant or award	13587	0	13,587	2 days	Filed terms security Title: Stock Option (Right to Buy) conversion Or Exercise Price: 12.50 transaction Date: 2026-10-19 transaction Form Type: 4 transaction Code: A equity Swap Involved: false transaction Shares: 13587 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-10-19 underlying Security Title: Common Stock underlying Security Shares: 13587 shares Owned Following Transaction: 13587 direct Or Indirect Ownership: D

Owner: Germano Geno J
Date: 2026-10-19
Code: A
Action: Grant or award
Quantity: 13587
Price: 0
Following holdings: 13,587
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Option (Right to Buy)
conversion Or Exercise Price: 12.50
transaction Date: 2026-10-19
transaction Form Type: 4
transaction Code: A
equity Swap Involved: false
transaction Shares: 13587
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-10-19
underlying Security Title: Common Stock
underlying Security Shares: 13587
shares Owned Following Transaction: 13587
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Germano Geno J: Director.
F1: The stock option will vest, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date, in 24 substantially equal monthly installments on the last day of the month so that the option will be fully vested and exercisable on the last day of the month of the second anniversary of the grant date.

Prepared automatically from public filing data. Report a correction.